Cargando…
Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome
BACKGROUND: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. AIM: The objective of the study was to investigate whether angiopoietin-2 levels are associated...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279058/ https://www.ncbi.nlm.nih.gov/pubmed/34316229 http://dx.doi.org/10.4103/jhrs.jhrs_179_20 |
_version_ | 1783722380314542080 |
---|---|
author | Rajendiran, Luxmipratha Nandeesha, Hanumanthappa Chitra, Thyagaraju |
author_facet | Rajendiran, Luxmipratha Nandeesha, Hanumanthappa Chitra, Thyagaraju |
author_sort | Rajendiran, Luxmipratha |
collection | PubMed |
description | BACKGROUND: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. AIM: The objective of the study was to investigate whether angiopoietin-2 levels are associated with inflammation and CC resistance in PCOS. SETTINGS AND DESIGN: This study was conducted in a tertiary care hospital. MATERIALS AND METHODS: Eighty-one women diagnosed with PCOS and on treatment with CC were enrolled in the study. Angiopoeitin-2 and IL -23 were analyzed in all the subjects. RESULTS: Angiopoietin-2 was significantly reduced (P = 0.018), and body mass index (BMI) (P = 0.049) and duration of infertility (0.006) were significantly increased in PCOS women with CC resistance compared to those who are sensitive to CC. In CC resistant PCOS, IL-23 predicts reduction in angiopoietin-2 levels (P = 0.010). Among angiopoietin-2, IL-23, BMI, and duration of infertility, we found that angiopoeitn-2 (P = 0.020) and duration of infertility (0.036) can predict resistance to CC therapy among PCOS subjects. CONCLUSION: We conclude that reduced angiopoietin-2 levels predict CC resistance in women with PCOS. |
format | Online Article Text |
id | pubmed-8279058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-82790582021-07-26 Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome Rajendiran, Luxmipratha Nandeesha, Hanumanthappa Chitra, Thyagaraju J Hum Reprod Sci Original Article BACKGROUND: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. AIM: The objective of the study was to investigate whether angiopoietin-2 levels are associated with inflammation and CC resistance in PCOS. SETTINGS AND DESIGN: This study was conducted in a tertiary care hospital. MATERIALS AND METHODS: Eighty-one women diagnosed with PCOS and on treatment with CC were enrolled in the study. Angiopoeitin-2 and IL -23 were analyzed in all the subjects. RESULTS: Angiopoietin-2 was significantly reduced (P = 0.018), and body mass index (BMI) (P = 0.049) and duration of infertility (0.006) were significantly increased in PCOS women with CC resistance compared to those who are sensitive to CC. In CC resistant PCOS, IL-23 predicts reduction in angiopoietin-2 levels (P = 0.010). Among angiopoietin-2, IL-23, BMI, and duration of infertility, we found that angiopoeitn-2 (P = 0.020) and duration of infertility (0.036) can predict resistance to CC therapy among PCOS subjects. CONCLUSION: We conclude that reduced angiopoietin-2 levels predict CC resistance in women with PCOS. Wolters Kluwer - Medknow 2021 2021-06-28 /pmc/articles/PMC8279058/ /pubmed/34316229 http://dx.doi.org/10.4103/jhrs.jhrs_179_20 Text en Copyright: © 2021 Journal of Human Reproductive Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Rajendiran, Luxmipratha Nandeesha, Hanumanthappa Chitra, Thyagaraju Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome |
title | Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome |
title_full | Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome |
title_fullStr | Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome |
title_full_unstemmed | Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome |
title_short | Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome |
title_sort | reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279058/ https://www.ncbi.nlm.nih.gov/pubmed/34316229 http://dx.doi.org/10.4103/jhrs.jhrs_179_20 |
work_keys_str_mv | AT rajendiranluxmipratha reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome AT nandeeshahanumanthappa reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome AT chitrathyagaraju reducedangiopoietin2asapredictivebiomarkerforclomiphenecitrateresistanceinpolycysticovarysyndrome |